Innate Pharma SA is a France-based biopharmaceutical Company that develops drugs for treatment of cancer and inflammatory diseases. The Company identifies and characterizes drug candidates, selects indications and manages the pre-clinical and clinical development of products. Innate Pharma primarily focuses on the development of new therapeutic solutions and monoclonal antibodies for the treatment of cancer, as well as for the treatment of infectious diseases and chronic inflammatory pathologies. The Company develops two categories of immunotherapies: immuno-modulators and cytotoxic antibodies. The Company works in collaboration with Bristol-Myers Squibb for Phase I cancer antibody program and with Novo Nordisk A/S for two antibody programs in inflammation treatment. The Company operates through anti-NKG2A antibody, an immune checkpoint inhibitor ready for Phase II development in oncology from Novo Nordisk.

Pharmaceutical

Innate Pharma SA

Mondher Mahjoubi

Odile Laurent

Claire De Saint Blanquat

Henry Wheeler

Frederic Lombard

Odile Belzunce

Nicola Beltraminelli

Yannis Morel

Eric Vivier

Laure-Hélène Mercier

Joyson Karakunnel

Board of Directors

Leadership Team

CEO and Executive Team

Innate Pharma SA

Org chart

Teams

Board of Directors

Leadership Team

CEO and Executive Team

Discover similar companies